Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
49.02
-0.98 (-1.96%)
Oct 31, 2025, 4:00 PM EDT
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of $216.87 billion as of October 31, 2025. Its market cap has decreased by -58.28% in one year.
Market Cap
216.87B
Enterprise Value
229.28B
Revenue
49.11B
Ranking
n/a
PE Ratio
12.40
Stock Price
$49.02
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 7.15B to 216.87B, an increase of 2,934.56%. That is a compound annual growth rate of 12.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 216.87B | -43.79% |
| Dec 30, 2024 | 385.82B | -16.41% |
| Dec 29, 2023 | 461.55B | 51.61% |
| Dec 30, 2022 | 304.43B | 19.34% |
| Dec 30, 2021 | 255.09B | 56.58% |
| Dec 30, 2020 | 162.91B | 19.30% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 563.78M |
| Northwest Biotherapeutics | 377.06M |
| Silence Therapeutics | 338.20M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |